Stay updated on SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial
Sign up to get notified when there's something new on the SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial page.

Latest updates to the SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial page
- Check5 days agoChange DetectedThe study history now includes additional version entries around late September 2026 and a Study Status update, while an older 2026-08-31 entry appears removed, reflecting updated record history for the trial.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s Revision tag has been updated to v3.7.0, replacing v3.6.6. This reflects a software version update for the page without altering its content.SummaryDifference0.0%

- Check33 days agoChange DetectedA new revision entry (v3.6.6) was added to the study record history on 2026-08-31, including a Study Status element, while the earlier revision entry (v3.6.5) from 2026-08-03 was removed.SummaryDifference0.2%

- Check55 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the page, indicating a software version upgrade. The update does not alter the page content or structure.SummaryDifference0.0%

- Check62 days agoChange DetectedA new history entry on 2026-08-03 labeled 'Study Status' with version 128 was added to the record history. The 2026-07-06 entry was removed.SummaryDifference0.1%

- Check69 days agoChange DetectedThe footer now shows Revision: v3.6.4 instead of v3.6.3, indicating a newer build of ClinicalTrials.gov; no study data or page functionality are altered by this change.SummaryDifference0.0%

Stay in the know with updates to SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial page.